Skip to content
OpenCapital
Get started

Xtant Medical Holdings XTNT Proceeds From Divestiture

Proceeds From Divestiture at other companies

Leggett & Platt logo
Leggett & PlattLEG
$10.1M+80.4%
MTD
Matador ResourcesMTDR
$5.61M+81.3%
Star Group, L.P. logo
Star Group, L.P.SGU
$0—
Xerox Holdings Corporation logo
Xerox Holdings CorporationXRX
$2M-92.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$75.75K+5,960%
PepsiCo logo
PepsiCoPEP
$9.75M-76.5%

Other financials

Income statement

See full
Revenue$20.9M-36.5%
Gross profit$12.0M-40.9%
Operating income-$2.9M-375%
Net income-$3.1M-5,426%
EPS (diluted)-$0.02—

Balance sheet

See full
Cash & equivalents$12.2M+124%
Total debt$15.0M-34.9%
Total equity$48.6M+10.8%
Total assets$78.0M-18.6%

Cash flow

See full
Operating cash flow-$2.1M-265%
CapEx$194.0K-83.7%
Free cash flow-$2.3M-2,753%

Valuation

See full
Market cap$59.05M-32.5%
Enterprise value$61.89M-41.5%
P/E32.3×—
P/S0.5×-0.2×

Profitability

See full
Gross margin62.3%+4.2pp
Operating margin4.8%+2.8pp
Net margin1.5%+0.8pp
FCF margin6.4%+4.1pp

Returns & leverage

See full
Return on equity3.9%+2.1pp
Debt / equity0.3×-0.2×
Current ratio3.3×+1.0×

Where this comes from

Reported directly by Xtant Medical Holdings in its filing.

Tagged under the XBRL concept XTNT:ProceedsFromDivestiture.

The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xtant Medical Holdings's proceeds from divestiture.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xtant Medical Holdings's proceeds from divestiture?
Xtant Medical Holdings (XTNT) reported proceeds from divestiture of $10.37M in Q1 2026.
How has Xtant Medical Holdings's proceeds from divestiture changed year-over-year?
Xtant Medical Holdings's proceeds from divestiture increased by 312.7% year-over-year, from $2.51M to $10.37M.
What does proceeds from divestiture mean?
Cash inflows resulting from the sale of business units, product lines, or other significant assets. This metric reflects the company's strategy for optimizing its portfolio and generating liquidity through the disposal of non-core assets. It is a key indicator of capital recycling and the company's ability to monetize assets to fund future growth or debt repayment.